Nautilus Biotechnolgy, Inc. Common Stock (NAUT) is a publicly traded Healthcare sector company. As of October 27, 2026, NAUT trades at $2.46 with a market cap of $412.31M and a P/E ratio of -4.01. NAUT moved +0.82% today. Year to date, NAUT is +27.75%; over the trailing twelve months it is +100.00%. Its 52-week range spans $0.62 to $4.31. Analyst consensus is strong buy with an average price target of $3.83. Rallies surfaces NAUT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NAUT, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $2.46 |
| Market Cap | $412.31M |
| P/E Ratio | -4.01 |
| EPS | $-0.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.31 |
| 52-Week Low | $0.62 |
| Volume | 339.66K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-59.00M |
| Gross Margin | 0.00% |
3 analysts cover NAUT: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.83.